Karyopharm Therapeutics Inc. - stock earnings
KPTI Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| July 31, 2024 BeforeMarket | - / - | 33.6 million | - / 36.2 million | 38.1 million |
KPTI Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -37.4 million USD | 33.1 million USD |
| 2023Q4 | -41.8 million USD | 33.7 million USD |
| 2023Q3 | -34.5 million USD | 36.0 million USD |
| 2023Q2 | -32.6 million USD | 37.6 million USD |
| 2023Q1 | -34.1 million USD | 38.7 million USD |
| 2022Q4 | -38.5 million USD | 33.6 million USD |
| 2022Q3 | -36.3 million USD | 36.1 million USD |
| 2022Q2 | -49.1 million USD | 39.7 million USD |
| 2022Q1 | -41.4 million USD | 47.7 million USD |
| 2021Q4 | 38.7 million USD | 126.3 million USD |
| 2021Q3 | -51.8 million USD | 37.7 million USD |
| 2021Q2 | -53.6 million USD | 22.6 million USD |
| 2021Q1 | -57.4 million USD | 23.3 million USD |
| 2020Q4 | -43.4 million USD | 35.1 million USD |
| 2020Q3 | -53.5 million USD | 21.3 million USD |
| 2020Q2 | -46.4 million USD | 33.5 million USD |
| 2020Q1 | -52.9 million USD | 18.1 million USD |
| 2019Q4 | -48.6 million USD | 18.1 million USD |
| 2019Q3 | -41.4 million USD | 13.1 million USD |
| 2019Q2 | -43.4 million USD | 9.5 million USD |
| 2019Q1 | -66.2 million USD | 155000 USD |
| 2018Q4 | -58.2 million USD | 206000 USD |
| 2018Q3 | -48.1 million USD | 239000 USD |
| 2018Q2 | -33.7 million USD | 19.9 million USD |
| 2018Q1 | -38.5 million USD | 10.0 million USD |
| 2017Q4 | -39.0 million USD | 1.5 million USD |
| 2017Q3 | -30.6 million USD | 3000 USD |
| 2017Q2 | -29.4 million USD | 3000 USD |
| 2017Q1 | -29.9 million USD | 68000 USD |
| 2016Q4 | -26.9 million USD | 47000 USD |
| 2016Q3 | -25.4 million USD | 48000 USD |
| 2016Q2 | -30.2 million USD | 59000 USD |
| 2016Q1 | -27.1 million USD | 25000 USD |
| 2015Q4 | -29.0 million USD | 25000 USD |
| 2015Q3 | -30.4 million USD | 75000 USD |
| 2015Q2 | -32.7 million USD | 150000 USD |
| 2015Q1 | -26.1 million USD | 15000 USD |
| 2014Q4 | -25.9 million USD | 16000 USD |
| 2014Q3 | -19.7 million USD | 21000 USD |
| 2014Q2 | -16.4 million USD | 21000 USD |
| 2014Q1 | -13.7 million USD | 171000 USD |
| 2013Q4 | -12.1 million USD | 21000 USD |
| 2013Q3 | -9.3 million USD | 133000 USD |
| 2013Q2 | -6.9 million USD | 133000 USD |
| 2013Q1 | -5.6 million USD | 233000 USD |
| 2012Q4 | -4.2 million USD | 33000 USD |
| 2012Q3 | -3.6 million USD | 34000 USD |
| 2012Q2 | ? USD | 567000 USD |
| 2011Q4 | ? USD | 152000 USD |
KPTI Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -143.1 million USD | 146.0 million USD |
| 2022 | -165.3 million USD | 157.1 million USD |
| 2021 | -124.1 million USD | 209.8 million USD |
| 2020 | -196.3 million USD | 108.1 million USD |
| 2019 | -199.6 million USD | 40.9 million USD |
| 2018 | -178.4 million USD | 30.3 million USD |
| 2017 | -129.0 million USD | 1.6 million USD |
| 2016 | -109.6 million USD | 154000 USD |
| 2015 | -118.2 million USD | 250000 USD |
| 2014 | -75.8 million USD | 229000 USD |
| 2013 | -33.9 million USD | 387000 USD |
| 2012 | -15.9 million USD | 634000 USD |
| 2011 | -10.3 million USD | 152000 USD |
KPTI
Price: $0.96
52 week price:
Earnings Per Share: -1.27 USD
P/E Ratio: -0.79
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.7 million
Ebitda: -30.9 millionMarket Capitalization: 133.6 million